Proteome Sciences (LON:PRM) Issues Earnings Results

Proteome Sciences (LON:PRM) posted its earnings results on Wednesday. The company reported GBX (0.41) EPS for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Stock Performance

Shares of PRM traded down GBX 0.19 during trading hours on Wednesday, hitting GBX 1.26. The stock had a trading volume of 534,540 shares, compared to its average volume of 374,873. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. Proteome Sciences has a 12 month low of GBX 1.11 and a 12 month high of GBX 4.40. The firm has a market capitalization of £4.42 million, a PE ratio of -1.21 and a beta of 0.16. The stock has a fifty day moving average price of GBX 1.71 and a 200 day moving average price of GBX 1.64.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.